ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Phio Pharmaceuticals Corporation

Phio Pharmaceuticals Corporation (PHIO)

2,35
-0,21
(-8,20%)
Geschlossen 14 November 10:00PM
2,36
0,01
(0,43%)
Nach Börsenschluss: 1:26AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
2,36
Gebot
2,34
Fragen
2,60
Volumen
24.996
2,34 Tagesbereich 2,6399
2,35 52-Wochen-Bereich 18,81
Marktkapitalisierung
Handelsende
2,56
Handelsbeginn
2,60
Letzter Handelszeitpunkt
Finanzvolumen
US$ 61.945
VWAP
2,4782
Durchschnittliches Volumen (3 Mio.)
65.180
Ausgegebene Aktien
860.721
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,19
Gewinn pro Aktie (EPS)
-12,58
Erlöse
-
Nettogewinn
-10,83M

Über Phio Pharmaceuticals Corporation

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Camden, Delaware, USA
Gegründet
-
Phio Pharmaceuticals Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHIO. The last closing price for Phio Pharmaceuticals was US$2,56. Over the last year, Phio Pharmaceuticals shares have traded in a share price range of US$ 2,35 to US$ 18,81.

Phio Pharmaceuticals currently has 860.721 shares in issue. The market capitalisation of Phio Pharmaceuticals is US$2,20 million. Phio Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.19.

PHIO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.9-27.60736196323.263.72.35657632.92073573CS
4-0.65-21.59468438543.013.882.35986853.1275655CS
12-0.72-23.37662337663.0842.35651803.15093067CS
26-3.9481-62.58778396036.30817.56092.35641404.22147757CS
52-7-74.78632478639.3618.812.352924529.65525795CS
156-167.2-98.6081623024169.56261.362.35618150119.50135439CS
260-30.04-92.716049382732.41171.82.35715992173.66428818CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MVSTMicrovast Holdings Inc
US$ 0,7951
(340,01%)
1,08B
QUBTQuantum Computing Inc
US$ 2,66
(92,75%)
102,15M
PULMPulmatrix Inc
US$ 3,56
(73,66%)
3,63M
BTCTBTC Digital Ltd
US$ 17,65
(68,10%)
45,02M
NMHINatures Miracle Holding Inc
US$ 0,142
(65,69%)
1,33B
SYRSSyros Pharmaceuticals Inc
US$ 0,359
(-86,85%)
38,53M
GCTKGlucoTrack Inc
US$ 0,36
(-77,06%)
6,58M
PETWag Group Company
US$ 0,21
(-67,98%)
14,68M
GLXGGalaxy Payroll Group Ltd
US$ 6,24
(-56,39%)
2,96M
XFORX4 Pharmaceuticals Inc
US$ 0,2773
(-53,17%)
18,56M
NMHINatures Miracle Holding Inc
US$ 0,142
(65,69%)
1,33B
MVSTMicrovast Holdings Inc
US$ 0,7951
(340,01%)
1,08B
ELABElevai Labs Inc
US$ 0,0247
(31,38%)
540,25M
AGRIAgriFORCE Growing Systems Ltd
US$ 0,0486
(2,53%)
288,52M
NVDANVIDIA Corporation
US$ 146,27
(-1,36%)
188,11M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock